USD 0.27
(0.33%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 372 Thousand USD | 199.6% |
2022 | 124.16 Thousand USD | -94.52% |
2021 | 2.26 Million USD | -53.65% |
2020 | 4.88 Million USD | 39.73% |
2019 | 3.49 Million USD | 311.29% |
2018 | 850 Thousand USD | 1249.21% |
2017 | 63 Thousand USD | -41.12% |
2016 | 107 Thousand USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 9.38 Million USD | 218.11% |
2024 Q1 | 254 Thousand USD | -31.72% |
2023 Q1 | 139 Thousand USD | 11.95% |
2023 Q2 | 230 Thousand USD | 65.47% |
2023 Q3 | 210 Thousand USD | -8.7% |
2023 FY | 372 Thousand USD | 199.6% |
2023 Q4 | 372 Thousand USD | 77.14% |
2022 Q2 | 2.12 Million USD | -3.19% |
2022 FY | 124.16 Thousand USD | -94.52% |
2022 Q4 | 124.16 Thousand USD | -93.95% |
2022 Q3 | 2.05 Million USD | -3.34% |
2022 Q1 | 2.19 Million USD | -3.05% |
2021 Q1 | 4.53 Million USD | -7.21% |
2021 Q2 | 2.44 Million USD | -46.06% |
2021 Q3 | 2.35 Million USD | -3.68% |
2021 Q4 | 2.26 Million USD | -3.86% |
2021 FY | 2.26 Million USD | -53.65% |
2020 FY | 4.88 Million USD | 39.73% |
2020 Q4 | 4.88 Million USD | -3.09% |
2020 Q1 | 3.34 Million USD | -4.41% |
2020 Q3 | 5.04 Million USD | -2.96% |
2020 Q2 | 5.19 Million USD | 55.45% |
2019 Q1 | 4.11 Million USD | 384.0% |
2019 Q3 | 3.79 Million USD | -4.19% |
2019 Q4 | 3.49 Million USD | -7.83% |
2019 FY | 3.49 Million USD | 311.29% |
2019 Q2 | 3.95 Million USD | -3.77% |
2018 Q4 | 850 Thousand USD | 2733.33% |
2018 Q3 | 30 Thousand USD | -28.57% |
2018 Q2 | 42 Thousand USD | -20.75% |
2018 Q1 | 53 Thousand USD | -15.87% |
2018 FY | 850 Thousand USD | 1249.21% |
2017 Q4 | 63 Thousand USD | 0.0% |
2017 FY | 63 Thousand USD | -41.12% |
2016 FY | 107 Thousand USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Perspective Therapeutics, Inc. | - USD | -Infinity% |
Electromed, Inc. | 87 Thousand USD | -327.586% |
Senseonics Holdings, Inc. | 47.77 Million USD | 99.221% |
Xtant Medical Holdings, Inc. | 23.55 Million USD | 98.421% |